Biotechnology-related intellectual property matters have a long tradition at KRAUS & LEDERER and there is hardly any field in the life sciences which has been marked by such rapid scientific progress over the last years. Major scientific advances go hand in hand with a constantly evolving legal framework.

KRAUS & LEDERER has accompanied this development from the start and has represented clients in numerous cases of great health, agricultural and scientific importance. Several significant biotech decisions by the European Patent Office are based on cases handled by KRAUS & LEDERER.

KRAUS & LEDERERs biotech team consists of experienced patent attorneys and younger attorneys/trainees who have recently left university research. The team is able to cover a wide variety of biological, biomedical and biotechnological inventions including recombinant proteins, molecule diagnostics (SNP arrays, microsatellite DNA typing, PCR-based methods), gene therapy, various types of antibodies, RNA, biomarkers, vaccines, stem cells, transgenic plants and animals, bioinformatics methods, plant breeding innovations and microfluidic devices.

KRAUS & LEDERER is representing numerous biotechnology companies. The freedom to operate in the life science sector of larger companies is today fairly often restricted or totally blocked by basic patents. KRAUS & LEDERER has ample experience in opposition, appeal and nullity proceedings with respect to such issues.

Biotechnological inventions often require interdisciplinary skill and counseling. Since KRAUS & LEDERER has scientifically trained patent attorneys and patent experts specializing in all major areas of modern technology a competent and full service can be offered for such cases.

Finally, KRAUS & LEDERER is part of an expert network in the biotech field. This allows us to bring our clients in contact with useful expertise concerning, inter alia, business development, start-up financing and regulatory approval.